Urogenital infections in patients with diabetes mellitus: Beyond the conventional aspects

Int J Immunopathol Pharmacol. 2019 Jan-Dec:33:2058738419866582. doi: 10.1177/2058738419866582.

Abstract

Diabetes mellitus (DM) is a widespread disease in our country. Urogenital infections, including urinary tract infections, vaginitis, balanitis, balanoposthitis, and male accessory gland infections, show a higher risk of occurrence in patients with DM that non-diabetic subjects. Both non-drug-related and drug-related mechanisms are involved in their pathogenesis. These conditions may impact on glucose control and islets function in DM and more likely develop into adverse complications. A throughout microbial characterization, including the drug-sensitivity test, is required for a proper management. To reduce the risk of recurrence, combined treatment, including antibiotic, anti-inflammatory, and fibrinolytic molecules, should be prescribed also to the sexual partner. The choice of the antidiabetic drug to prescribe should take into consideration the presence of urogenital infections. In conclusion, urogenital infections may more likely lead to complication in diabetic than non-diabetic patients, affect fertility and glucose control. Therefore, they need proper management.

Keywords: MAGI; UTIs; balanitis; diabetes mellitus; urogenital infections; vaginitis.

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / etiology*

Substances

  • Anti-Bacterial Agents
  • Hypoglycemic Agents